期刊文献+

心肌酶在重症肺炎的临床应用 被引量:6

Clinical application of cardiac enzymes in severe pneumonia
下载PDF
导出
摘要 目的研究肺炎患者心肌酶变化情况及心肌酶对重症肺炎的临床应用价值。方法以383例肺炎患者为研究对象,比较重症肺炎与普通肺炎心肌酶水平差异及不同病原体感染引起重症肺炎心肌酶异常率,并研究重症肺炎组中心肌酶异常患者与心肌酶正常患者心电图异常情况、心衰等并发症的发生率及死亡率。结果重症肺炎组、普通肺炎组心肌酶比较均有统计学差异(P<0.05);病毒性肺炎较易引起心肌酶异常;重症肺炎中心肌酶异常组与心肌酶正常组比较,心电图异常率及心衰发生率比较有统计学差异(P<0.05)。结论心肌酶对重症肺炎合并心肌损伤有重要监测作用,对重症肺炎病情评估有重要临床应用价值。 Objective To study the changes of cardiac enzymes in patients with pneumonia and its clinical significance.Methods 383 patients with pneumonia were selected in this study to compare the different levels of cardiac enzymes between patients with severe pneumonia and ordinary pneumonia and the abnormality of cardiac enzymes of patients with severe pneumonia caused by different pathogens.Besides,the abnormality of ECG,the incidence of complications and the mortality were analyzed and compared between patients with severe pneumonia with different levels of cardiac enzymes.Results There was significant difference of myocardial enzyme between the severe pneumonia group and the common pneumonia group(P〈0.05).The differences of ECG and incidence of heart failure showed a statistical significance between patients with severe pneumonia with different levels of cardiac enzymes(P〈0.05).Conclusion Cardiac enzymes play an important role in the monitoring of myocardial injury severe pneumonia and have important clinical value in the assessment of severe pneumonia condition.
作者 刘桑
机构地区 广西龙潭医院
出处 《临床肺科杂志》 2013年第8期1385-1386,共2页 Journal of Clinical Pulmonary Medicine
关键词 心肌酶 重症肺炎 心肌损伤 心衰 cardiac enzymes severe pneumonia myocardial injury heart failure
  • 相关文献

参考文献7

二级参考文献21

共引文献43

同被引文献53

  • 1马沛然,黄磊.重症肺炎时心肌bcl-2、bax基因表达及相关因素的实验研究[J].山东医药,2006,46(22):1-2. 被引量:2
  • 2黄磊,刘霞,邢韦韦,袁久莉,刘子岳.重症肺炎大鼠心脏结构和功能的改变[J].山东医药,2007,47(31):21-23. 被引量:2
  • 3Xu JT, Huang YL,Yuan XZ,et al. Hemedynamic changes induced by thrombolytic therapy in experimental acute pulmonary embolism [J].Chin J Cardiol,2012,24(3):225-227.
  • 4Giannitsis E,Muller-Bardoeff M,Kurowski V, et al.Independent prognostic value of cardiac tropnin T in patients with confirmed pulmonary embolism[J].Circulation,2010,102(2):211-217.
  • 5Yeh ET, Anderson HV, Pasceri V, et al.C,reactive protein linking inflammation to cardiovascular complications[J].Circulation,201 1,4(9):974-976.
  • 6Puglisi MJ,Femandez ML.Modulation of C-reactive protein,tumor necrosis factor alpha ,and adiponectin by diet ,exercise ,and weight loss [J].J Nutr,2010,138(12):2293-2296.
  • 7Miyagishima K,Hiramitsu S,Kato S,et al.Efficacy of atorvastatin therapy in isehaemie heart disease: effects on oxidized low density lipoprotein and adiponection[J].J Int Med Res,2012,35(4):534-539.
  • 8Fortmann SP, Flora JA,Winkeby MA,et al.Community intervention trials: reflections on the Stanford Five-City Project Experience[J].Am J Epidemiol,2010,142(11):576-586.
  • 9Munoz Mendoza J, Sun S,Chertow GM,et al.Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach[J].Nephrol Dial Transplant,2011,26(3):1281-127.
  • 10Idicula TT,Brogger J,Naess H,et al.Adm ission C-reactive protein after acute ischemic stroke is associated with stroke severity and morta lity: the Bergen stroke study[J].BMC Neurol,2011,28(9):18-22.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部